For all the attention artificial intelligence commands, one fact remains stubbornly consistent: Between 85% and 95% of AI projects still fail. Not because the technology is immature, but because ...
Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks ...